Juniper Pharmaceuticals

Juniper Pharmaceuticals develops medical drugs to address women's health issues. Its main products include JNP-0101, an oxybutynin IVR for treating overactive bladder in women; JNP-0201, an estrogen + progesterone IVR combination for menopausal symptoms; and JNP-0301, a progesterone IVR to prevent preterm birth in women with short cervical length during the second trimester of pregnancy.